Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hanchun Chen

Showing results (51-60 of 58) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 58 results.
BMC Cancer|April 15, 2022
Proteomics analysis: inhibiting the expression of P62 protein by chloroquine combined with dacarbazine can reduce the malignant progression of uveal melanomaXifeng Fei, Xiangtong Xie, Ruwei Qin, et al.
Cancer Biomarkers : Section a of Disease Markers|September 6, 2024
Glioma stem cells remodel immunotolerant microenvironment in GBM and are associated with therapeutic advancementsXifeng Fei, Jie Wu, Haiyan Tian, et al.
International Journal of Biological Sciences|April 13, 2022
COVID-19 receptor and malignant cancers: Association of <i>CTSL</i> expression with susceptibility to SARS-CoV-2Lianmei Zhang, Chunli Wei, Dabing Li, et al.
Bioorganic Chemistry|August 7, 2025
TQFL13, a novel synthetic derivative of thymoquinone (TQ), is more capable of inhibiting breast cancer progression than TQChunli Wei, Jingliang Cheng, Hui Zou, et al.
Journal of Hazardous Materials|August 27, 2024
Bacterial mercury methylation modulated by vitamin B9: An overlooked pathway leads to increased environmental risksFang Fang, Lingyun Ding, Yaoyu Zhang, et al.
Scientific Reports|July 15, 2016
Tripartite motif containing 28 (TRIM28) promotes breast cancer metastasis by stabilizing TWIST1 proteinChunli Wei, Jingliang Cheng, Boxv Zhou, et al.
Oncotarget|February 9, 2018
Genetic identification and molecular modeling characterization reveal a novel <i>PROM1</i> mutation in Stargardt4-like macular dystrophySaber Imani, Jingliang Cheng, Marzieh Dehghan Shasaltaneh, et al.
Molecules (Basel, Switzerland)|November 11, 2022
Impact of <i>TMPRSS2</i> Expression, Mutation Prognostics, and Small Molecule (CD, AD, TQ, and TQFL12) Inhibition on Pan-Cancer Tumors and Susceptibility to SARS-CoV-2Jiewen Fu, Shuguang Liu, Qi Tan, et al.
Pageof 6

Showing results (51-60 of 58) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 58 results.
BMC Cancer|April 15, 2022
Proteomics analysis: inhibiting the expression of P62 protein by chloroquine combined with dacarbazine can reduce the malignant progression of uveal melanomaXifeng Fei, Xiangtong Xie, Ruwei Qin, et al.
Cancer Biomarkers : Section a of Disease Markers|September 6, 2024
Glioma stem cells remodel immunotolerant microenvironment in GBM and are associated with therapeutic advancementsXifeng Fei, Jie Wu, Haiyan Tian, et al.
International Journal of Biological Sciences|April 13, 2022
COVID-19 receptor and malignant cancers: Association of <i>CTSL</i> expression with susceptibility to SARS-CoV-2Lianmei Zhang, Chunli Wei, Dabing Li, et al.
Bioorganic Chemistry|August 7, 2025
TQFL13, a novel synthetic derivative of thymoquinone (TQ), is more capable of inhibiting breast cancer progression than TQChunli Wei, Jingliang Cheng, Hui Zou, et al.
Journal of Hazardous Materials|August 27, 2024
Bacterial mercury methylation modulated by vitamin B9: An overlooked pathway leads to increased environmental risksFang Fang, Lingyun Ding, Yaoyu Zhang, et al.
Scientific Reports|July 15, 2016
Tripartite motif containing 28 (TRIM28) promotes breast cancer metastasis by stabilizing TWIST1 proteinChunli Wei, Jingliang Cheng, Boxv Zhou, et al.
Oncotarget|February 9, 2018
Genetic identification and molecular modeling characterization reveal a novel <i>PROM1</i> mutation in Stargardt4-like macular dystrophySaber Imani, Jingliang Cheng, Marzieh Dehghan Shasaltaneh, et al.
Molecules (Basel, Switzerland)|November 11, 2022
Impact of <i>TMPRSS2</i> Expression, Mutation Prognostics, and Small Molecule (CD, AD, TQ, and TQFL12) Inhibition on Pan-Cancer Tumors and Susceptibility to SARS-CoV-2Jiewen Fu, Shuguang Liu, Qi Tan, et al.
Pageof 6